ALSP Orchid is a newly organized blank check company formed by Accelerator for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While ALSP Orchid may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to pursue investments in North America and Singapore with an emphasis on life science companies developing assets and next-generation platform technologies with broad applicability.

The Accelerator management team has established an exceptional track record of identifying disruptive opportunities, advising, building, and successfully exiting biotechnology companies. Leveraging this significant operating, clinical, technical, and transactional experience across all sectors of healthcare, Accelerator’s reputation as a trusted partner and ALSP Orchid’s accomplished team of investment professionals and advisors provides a competitive advantage.